Abstract
Viruses often encode proteins that mimic host proteins in order to facilitate infection. Little work has been done to understand the potential mimicry of the SARS-CoV-2, SARS-CoV, and MERS-CoV spike proteins, particularly the receptor-binding motifs (RBMs), which could be important in determining the tropism of the virus. Here, we use structural bioinformatics software to characterize potential mimicry of the three coronavirus spike protein RBMs. We utilize sequence-independent alignment tools to compare structurally known or predicted three-dimensional protein models with the RBMs and verify potential mimicry with protein docking simulations. Both human and non-human proteins were found to be similar to all three RBMs. Similarity to human proteins may reveal which pathways the spike protein is co-opting, while analogous non-human proteins may indicate shared host interaction partners and overlapping antibody cross-reactivity. These findings can help guide experimental efforts to further understand potential interactions between human and coronavirus proteins.
Introduction: The Challenge of Molecular Mimicry
While the primary entry mechanism for SARS-CoV-2 via the ACE2 receptor is well-documented, the full spectrum of coronavirus interactions with human biology remains largely unexplored. Highly pathogenic coronaviruses—SARS-CoV-2, SARS-CoV, and MERS-CoV—often employ molecular mimicry, evolving protein motifs that physically resemble host proteins to "trick" cellular machinery.
A significant challenge in identifying these mimics is that structural similarity does not always require sequence identity; proteins with vastly different amino acid sequences can fold into nearly identical 3D shapes. This study addresses the gap in our understanding of how the Receptor-Binding Motifs (RBMs) of major coronaviruses mimic known protein structures, potentially explaining multi-organ tropism and complex immune responses.
Methods: A Structural Bioinformatics Pipeline
To identify potential mimics, researchers employed a multi-stage computational pipeline focused on 3D shape rather than genetic sequence:
- Homology Modeling: High-quality 3D models of the trimeric spike proteins for SARS-CoV-2, SARS-CoV, and MERS-CoV were constructed using ProtCHOIR.
- Sequence-Independent Structural Alignment: Four distinct 3D alignment tools (PDBeFold, RUPEE, HMI-PRED, and TM-align) were used to scan the Protein Data Bank (PDB) for structural matches to the viral RBMs. This approach ensures that mimicry resulting from convergent evolution in folding is captured.
- Functional Filtering: The search was narrowed to proteins found in the extracellular matrix and excluded antibodies to focus on functional mimics that might interact with host receptors.
- Docking & Energy Simulation: To validate the biological plausibility of these hits, protein-protein docking was performed using ClusPro PIPER. Interaction energies were calculated with FoldX to determine if a viral RBM could realistically bind to a human receptor with an affinity comparable to the natural human ligand.
Key Insights and Results
The screen identified 62 unique protein families that structurally resemble the viral RBMs. A key finding was that structural similarity is a far more reliable predictor of mimicry than sequence identity, as many high-confidence hits showed very low sequence homology.
Co-opting Host Pathways
All three viruses were found to mimic EGF-like domains present in coagulation factors (such as Factor VIIa) and thrombomodulin. This structural mimicry may provide a mechanistic explanation for the severe blood-clotting issues, or coagulopathies, frequently observed in COVID-19 patients. Furthermore, the RBMs mimic cytokines and chemokines, including IL-8 and IL-6 receptors, suggesting the virus may directly modulate the "cytokine storm" or interfere with immune signaling.
Cross-Species and Toxin Mimicry
- Malaria Link: SARS-CoV-2 RBMs were found to mimic proteins from Plasmodium (the malaria parasite), suggesting potential antibody cross-reactivity that could influence disease outcomes in malaria-endemic regions.
- Toxin Mimicry: The study identified motifs similar to snake and spider toxins that target receptors involved in pain and nociception. This could explain clinical symptoms like altered pain perception or the loss of taste and smell.
Quantitative Validation
SARS-CoV and SARS-CoV-2 exhibited high structural similarity to each other (TM-score 0.711), while MERS-CoV remained more distinct. Docking simulations confirmed that viral RBMs often bind to human receptors, such as Thrombin or FGFR2, with affinities comparable to natural ligands. Notably, the MERS-CoV RBM was predicted to bind to the complement receptor C3 with even higher affinity than the natural control.
Discussion and Future Directions
While these in silico results provide a compelling map of potential viral-host interactions, they represent a starting point for experimental validation. The primary limitation is the computational nature of the study; these predicted interactions must be confirmed through "wet lab" assays such as surface plasmon resonance.
Additionally, the dynamic flexibility of the spike protein's cystine disulfide loop presents a challenge for static modeling. Future research will focus on testing these specific predicted interactions to determine if they can be targeted by novel inhibitory drugs or therapeutic peptides to prevent the hijacking of host biological pathways.
Summary updated